XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 69 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -99.3% | 368 | -98.8% | 0.00% | – |
| Q1 2021 | $139,000 | +41.8% | 30,757 | +54.1% | 0.00% | – |
| Q4 2020 | $98,000 | -5.8% | 19,957 | +14.3% | 0.00% | – |
| Q3 2020 | $104,000 | +126.1% | 17,457 | 0.0% | 0.00% | – |
| Q2 2020 | $46,000 | +35.3% | 17,457 | 0.0% | 0.00% | – |
| Q1 2020 | $34,000 | -72.4% | 17,457 | 0.0% | 0.00% | – |
| Q4 2019 | $123,000 | -57.0% | 17,457 | -39.9% | 0.00% | – |
| Q3 2019 | $286,000 | +21.2% | 29,057 | +40.7% | 0.00% | – |
| Q2 2019 | $236,000 | +505.1% | 20,657 | +429.7% | 0.00% | – |
| Q1 2019 | $39,000 | -40.9% | 3,900 | 0.0% | 0.00% | – |
| Q4 2018 | $66,000 | – | 3,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 3,661,237 | $8,970,000 | 0.44% |
| Alpine Global Management, LLC | 370,000 | $907,000 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 460,500 | $1,128,000 | 0.17% |
| IHT Wealth Management, LLC | 334,367 | $819,000 | 0.07% |
| Redmile Group, LLC | 1,358,825 | $3,329,000 | 0.06% |
| GPS Wealth Strategies Group, LLC | 58,025 | $142,000 | 0.04% |
| Granahan Investment Management | 465,049 | $1,139,000 | 0.02% |
| SEARLE & CO. | 20,000 | $49,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 402,300 | $986,000 | 0.02% |
| Gladstone Institutional Advisory LLC | 53,500 | $131 | 0.01% |